Poxvirus vector Modified Vaccinia Pathogen Ankara (MVA) expressing HIV-1 Env, Gag, Nef and Pol antigens from clade N (termed MVA-B) is a promising HIV/Helps vaccine applicant, while confirmed from outcomes obtained in a prophylactic stage We clinical trial in human beings. [27], that is a known member of the VACV Bcl-2 family members [28]. encodes… Continue reading Poxvirus vector Modified Vaccinia Pathogen Ankara (MVA) expressing HIV-1 Env, Gag,